Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 1973-1981, 2005. First published August 25, 2005; 10.1373/clinchem.2005.053694
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplements
Right arrow All Versions of this Article:
clinchem.2005.053694v1
51/10/1973    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurn, N.
Right arrow Articles by Wang, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurn, N.
Right arrow Articles by Wang, S.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Oak Ridge Conference
(Clinical Chemistry. 2005;51:1973-1981.)
© 2005 American Association for Clinical Chemistry, Inc.

Oak Ridge Conference

Novel Isothermal, Linear Nucleic Acid Amplification Systems for Highly Multiplexed Applications

Nurith Kurna, Pengchin Chen, Joe Don Heath, Anne Kopf-Sill, Kathryn M. Stephens and Shenglong Wang

1 NuGEN Technologies, Inc., 821 Industrial Rd., Unit A, San Carlos, CA 94070.

aAuthor for correspondence. Fax 650-622-9867; e-mail nkurn{at}nugeninc.com.


Abstract

Background: Global analysis of the genome, transcriptome, and proteome is facilitated by the recent development of tools for large-scale, highly parallel analysis. We describe a novel nucleic acid amplification system that generates products by several methods. 3'-Ribo-SPIATM primes cDNA synthesis at the 3' polyA tail, and whole transcript (WT)-Ribo-SPIA primes cDNA synthesis across the full length of the transcripts and thus provides whole-transcriptome amplification, independent of the 3' polyA tail.

Methods: We developed isothermal linear nucleic acid amplification systems, which use a single chimeric primer, for amplification of DNA (SPIA) and RNA (Ribo-SPIA). The latter allows mRNA amplification from as little as 1 ng of total RNA. Amplification efficiency was calculated based on the delta threshold cycle between nonamplified cDNA targets and amplified cDNA. The amounts and quality of total RNA and amplification products were determined after purification of the amplification products. GeneChip® array gene expression profiling and real-time PCR were used to test the accuracy and reproducibility of the method. Quantification of cDNA products (before and after amplification) at the 2 loci along the transcripts was used to assess product length (for evaluation of the 3'-initiated Ribo-SPIA) and equal representation throughout the length of the transcript (for evaluation of the whole transcript amplification system, WT-Ribo-SPIATM).

Results: Ribo-SPIA–based global RNA amplification exhibited linearity over 6 orders of magnitude of transcript abundance and generated microgram amounts of amplified cDNA from as little as 1 ng of total RNA.

Conclusions: The described methods enable comprehensive gene expression profiling and analysis from limiting biological samples. The WT-Ribo-SPIA procedure, which enables amplification of non–polyA-tailed RNA, is suitable for amplification and gene expression analysis of both eukaryotic and prokaryotic biological samples.




The following articles in journals at HighWire Press have cited this article:


Home page
 Nucleic Acids ResHome page
J. Vermeulen, F. Pattyn, K. De Preter, L. Vercruysse, S. Derveaux, P. Mestdagh, S. Lefever, J. Hellemans, F. Speleman, and J. Vandesompele
External oligonucleotide standards enable cross laboratory comparison and exchange of real-time quantitative PCR data
Nucleic Acids Res., November 1, 2009; 37(21): e138 - e138.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
O. Peleg, G. Baneth, O. Eyal, J. Inbar, and S. Harrus
Use of Chimeric DNA-RNA Primers in Quantitative PCR for Detection of Ehrlichia canis and Babesia canis
Appl. Envir. Microbiol., October 1, 2009; 75(19): 6393 - 6398.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
I. Gilbert, S. Scantland, I. Dufort, O. Gordynska, A. Labbe, M.-A. Sirard, and C. Robert
Real-time monitoring of aRNA production during T7 amplification to prevent the loss of sample representation during microarray hybridization sample preparation
Nucleic Acids Res., May 1, 2009; 37(8): e65 - e65.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. H. Chung, J. S. Parker, K. Ely, J. Carter, Y. Yi, B. A. Murphy, K. K. Ang, A. K. El-Naggar, A. M. Zanation, A. J. Cmelak, et al.
Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-{kappa}B Signaling as Characteristics of a High-risk Head and Neck Squamous Cell Carcinoma
Cancer Res., August 15, 2006; 66(16): 8210 - 8218.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. J.C. Slebos, Y. Yi, K. Ely, J. Carter, A. Evjen, X. Zhang, Y. Shyr, B. M. Murphy, A. J. Cmelak, B. B. Burkey, et al.
Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., February 1, 2006; 12(3): 701 - 709.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.